Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin

By              

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 211-219

Spandidos Publications

Access to resources Recommend Favorite

The Implication of Compromised Renal Function at Presentation in Myeloma: Similar Outcome in Patients Who Receive High-Dose Therapy: A Single-Center Study of 251 Previously Untreated Patients

By Sirohi B.   Powles R.   Mehta J.   Treleaven J.   Raje N.   Kulkarni S.   Rudin C.   Bhagwati N.   Horton C.   Saso R.   Singhal S.   Parikh P.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 39-50

Humana Press, Inc

Access to resources Recommend Favorite

In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma

By          

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 955-968

Spandidos Publications

Access to resources Recommend Favorite

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

By Zori Comba A.   Blajman C.   Richardet E.   Bella S.   Vilanova M.   Coppola F.   Van Kooten M.   Rodger J.   Giglio R.   Balbiani L.   Perazzo F.   Montiel M.   Chacon M.   Pujol F.   Mickiewicz E.   Cazap E.   Recondo G.   Lastiri F.   Simon J.   Wasserman E.   Schmilovich A.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1006-1013

Elsevier

Access to resources Recommend Favorite

Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: A phase 2 trial

By Abou-Jawde Rony   Reed Janice   Kelly Megan   Walker Esteban   Andresen Steven   Baz Rachid   Karam Mary   Hussein Mohamad  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 263-272

Humana Press, Inc

Access to resources Recommend Favorite